Wealthspire Advisors (New York)’s Zimmer Biomet ZBH Stock Holding History

Wealthspire Advisors (New York)’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$876K	Buy	10,176 +88	+0.9%	+$7.72K	﹤0.01%	587
2026 Q1	$912K	Sell	10,088 -799	-7%	-$73.3K	0.01%	425
2025 Q4	$979K	Buy	10,887 +757	+7%	+$71.8K	0.01%	432
2025 Q3	$998K	Buy	10,130 +2,568	+34%	+$254K	0.01%	395
2025 Q2	$690K	Sell	7,562 -83	-1%	-$8.03K	﹤0.01%	460
2025 Q1	$865K	Buy	7,645 +44	+0.6%	+$4.71K	0.01%	404
2024 Q4	$803K	Sell	7,601 -1,137	-13%	-$122K	0.01%	416
2024 Q3	$943K	Buy	8,738 +194	+2%	+$21.2K	0.01%	381
2024 Q2	$927K	Buy	8,544 +1,020	+14%	+$120K	0.01%	325
2024 Q1	$993K	Sell	7,524 -540	-7%	-$67.5K	0.01%	317
2023 Q4	$981K	Buy	8,064 +488	+6%	+$54.5K	0.01%	313
2023 Q3	$850K	Buy	+7,576	New	+$962K	0.01%	305
2021 Q4	–	Sell	-1,758	Closed	-$250K	–	635
2021 Q3	$250K	Buy	+1,758	New	+$259K	0.01%	498
2021 Q2	–	Sell	-2,237	Closed	-$348K	–	684
2021 Q1	$348K	Buy	2,237 +821	+58%	+$127K	0.01%	509
2020 Q4	$212K	Buy	+1,416	New	+$200K	0.01%	536
2019 Q1	–	Sell	-140	Closed	-$14K	–	826
2018 Q4	$14K	Buy	+140	New	+$15.7K	﹤0.01%	427

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wealthspire Advisors (New York)'s ZBH Position: Q2 2026 in Review

Wealthspire Advisors (New York) increased its Zimmer Biomet (ZBH) stake by 0.87% in Q2 2026, buying an estimated $7.72K and bringing the position to 10,176 shares worth $876K. The position accounts for ﹤0.01% of the portfolio, ranked #587.

Wealthspire Advisors (New York) first reported a position in ZBH in Q4 2018 and has held it in 16 quarters since. The position peaked at $998K in Q3 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Wealthspire Advisors (New York) held 10,176 shares of Zimmer Biomet worth $876K as of Q2 2026.
Wealthspire Advisors (New York) bought 88 Zimmer Biomet shares in Q2 2026, an estimated $7.72K.
Zimmer Biomet made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #587 holding.
Wealthspire Advisors (New York) first reported a position in Zimmer Biomet in Q4 2018 and has held it in 16 quarters since.
Wealthspire Advisors (New York)'s Zimmer Biomet position peaked at $998K in Q3 2025.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.